CCO Oncology Podcast

185 Odcinki

1. Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

   Opublikowany: 12.03.2021
2. Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

   Opublikowany: 12.03.2021
3. Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias

   Opublikowany: 26.02.2021
4. Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer

   Opublikowany: 24.02.2021
5. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

   Opublikowany: 22.02.2021
6. Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders

   Opublikowany: 10.02.2021
7. Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms

   Opublikowany: 5.02.2021
8. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy

   Opublikowany: 4.02.2021
9. Expert Answers to Questions on Contemporary Management of Hemophilia A

   Opublikowany: 4.02.2021
10. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States

    Opublikowany: 1.02.2021
11. An Expert Overview of Immunotherapy for Advanced HCC

    Opublikowany: 19.01.2021
12. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

    Opublikowany: 8.01.2021
13. Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance

    Opublikowany: 28.12.2020
14. Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ

    Opublikowany: 24.12.2020
15. Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC

    Opublikowany: 21.12.2020
16. Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

    Opublikowany: 17.12.2020
17. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom

    Opublikowany: 20.11.2020
18. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France

    Opublikowany: 19.11.2020
19. Molecular Classification of Endometrial Carcinoma in the Clinic Today

    Opublikowany: 11.11.2020
20. Advances in Immunotherapy for Endometrial Cancer

    Opublikowany: 11.11.2020